Concepedia
Statistics
Publications
4
Citations
136
H-Index
Active since
2015
Affiliations
Novartis (Switzerland)(Current)
Novartis (United States)
Novartis Institutes for BioMedical Research
Adwait Oka is an author at Novartis (Switzerland) specializing in humoral immunity, antibody engineering, and tumor immunity.
Top concepts
MedicinePathologyImmunologyImmunotherapyTumor ImmunityAntibody BiologyHumoral ImmunityImmunodeficiencyAutoimmune DiseaseClinical Immunology
Publications per year
2015–2023
Combination wt-p53 and MicroRNA-125b Transfection in a Genetically Engineered Lung Cancer Model Using Dual CD44/EGFR-targeting Nanoparticles
Meghna Talekar, Malav Trivedi, Parin Shah et al. · Molecular Therapy · 2015 · 56 citations · Full text
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation
Hailin Chen, Tengteng Yu, Liang Lin et al. · Blood Cancer Journal · 2022 · 48 citations · Full text
PIT565, a First-in-Class Anti-CD19, Anti-CD3, Anti-CD2 Trispecific Antibody for the Treatment of B Cell Malignancies
Haihui Lu, Adwait Oka, Michelle Coulson et al. · Blood · 2022 · 19 citations
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
Marc S. Raab, Yaël C. Cohen, Fredrik Schjesvold et al. · Leukemia · 2023 · 13 citations
Clinical Immunology, Preclinical Discovery, Autoimmune Disease +11
1–4 of 4